genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Authors
Posts by Alex Philippidis
Alex Philippidis
A-Lists
Top 25 Biopharma IPOs of 2017
10 Takeover Targets of 2018
Industry News
Sanofi, Evotec Launch New “BRIDGE” Partnership to Accelerate Drug Discovery
Next Generation: Growing Protein Therapeutics Developer Raises $370M
Coronavirus
NRx Pharmaceuticals – BriLife®
Top 50 NIH-Funded Institutions of 2022
GEN Edge
The View from ARK Invest: A Discussion with Simon Barnett and Ali Urman
GEN Edge
How’s the Biotechnology Business? A Conversation with Chris Garabedian, Brad Loncar, and Daphne Zohar
GEN Edge
Lessons from the COVID Crisis: An Interview with Peter Hotez
Seven Biopharma Trends to Watch in 2023
1
2
3
…
9
>
Page 1 of 9
Recently Featured
Candida albicans
May Yield Ground to Newfound Commensal Fungus
T-Cell Therapy in Solid Tumors May Be Improved by Enzyme
UV-Damaged RNA in Daughter Cells Captured by Stress Granules
Syngene Expects Its New Biologics Manufacturing Facility in India to Be Operational from Mid-Year
Scroll Up